New lab test could identify imatinib resistance
Wednesday, July 28, 2010 - 23:14
in Health & Medicine
Scientists in Japan may have developed a way to accurately predict those patients who will resist treatment with imatinib, which is the standard of care for chronic myeloid leukemia (CML).